Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.91% is 147% above its 5-year average of -10.42%, near the high end of its 5-year range (-17.91%–4.91%).
251.54% above its 12-month average of -3.24%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 3.22%.
RETURN ON ASSETS (ROA)
4.91%
RETURN ON ASSETS (ROA) AVG TTM
-3.24%
RETURN ON ASSETS (ROA) AVG 3Y
-6.85%
RETURN ON ASSETS (ROA) AVG 5Y
-10.42%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+251.54%
CURRENT VS 3Y AVG
+171.71%
CURRENT VS 5Y AVG
+147.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-4.47%
vs the sector median at left
Oscar Health, Inc.
Market Cap
$8.33B
Return on Assets (ROA)
4.91%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$9.66B
Return on Assets (ROA)
3.54%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$9.74B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$9.99B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$6.59B
Return on Assets (ROA)
17.41%
TTM Avg
17.14%
3Y Avg
16.98%
5Y Avg
18.36%
Market Cap
$10.13B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$10.14B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$6.24B
Return on Assets (ROA)
-3.91%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
Market Cap
$10.48B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $8.33B | 4.91% | -3.24% | -6.85% | -10.42% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 3.54% | 3.68% | 4.39% | 5.01% |
| Insulet Corp. (PODD)vs › | $9.74B | 11.86% | 10.65% | 7.37% | 5.11% |
| Globus Medical, Inc. (GMED)vs › | $9.99B | 9.76% | 6.05% | 5.92% | 6.23% |
| Chemed Corporation (CHE)vs › | $6.59B | 17.41% | 17.14% | 16.98% | 18.36% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.13B | 2.17% | -6.26% | -11.14% | 1.46% |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 6.59% | 6.34% | 6.05% | 6.29% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | -3.91% | 11.88% | 0.12% | -6.73% |
| Molina Healthcare, Inc. (MOH)vs › | $10.48B | -0.04% | 5.29% | 6.08% | 6.13% |
| Align Technology, Inc. (ALGN)vs › | $10.57B | 6.44% | 6.68% | 6.69% | 12.75% |
ROA
4.9%
ROE
26.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -7.01% |
| 2024-12-31 | 0.53% |
| 2023-12-31 | -7.52% |
| 2022-12-31 | -13.39% |
| 2021-12-31 | -17.24% |
| 2020-12-31 | -17.91% |
| 2019-12-31 | -19.39% |
